Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
AIDS Res Ther ; 20(1): 24, 2023 04 21.
Artigo em Inglês | MEDLINE | ID: mdl-37085860

RESUMO

BACKGROUND: Expanding pre-exposure prophylaxis (PrEP) among transgender women in the United States is an important strategy to meet national HIV prevention goals, however self-reported use of PrEP is low in this group. METHODS: This study reports the findings of a cross-sectional analysis of the relationship of barriers as well as facilitators to recent PrEP use among transgender women enrolled in an evaluation of the TransLife Care project (Chicago, Illinois), a structural intervention designed to meet basic needs. We computed multivariable prevalence ratios for barriers, facilitators and recent PrEP use, controlling for demographics. RESULTS: Findings suggest that psychosocial and structural barriers, including moderate/high alcohol use, stimulant use, and history of incarceration were all positively associated with recent PrEP use among urban transgender women. In addition, a psychosocial facilitator, gender affirmation, was positively associated with recent PrEP use, while, while collective self-esteem, a was negatively associated with it. Finally, common indications for PrEP have high sensitivity, but low specificity and predictive value for identifying those on PrEP. CONCLUSION: We conclude that despite a large gap in PrEP use among those with indications, individuals experiencing psychosocial and structural barriers are more likely to use PrEP, and facilitators, such as psychological sense of affirmed gender may support its use. TRIAL REGISTRATION: N/A.


Assuntos
Profilaxia Pré-Exposição , Pessoas Transgênero , Humanos , Feminino , Adolescente , Adulto Jovem , Adulto , Estudos Transversais , Masculino , Pessoas Transgênero/psicologia , Chicago
2.
AIDS Educ Prev ; 36(3): 155-167, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38917300

RESUMO

Transgender women are disproportionately impacted by HIV infection. We report herein the findings of a pre-post evaluation of the TransLife Care (TLC) project in Chicago, Illinois, on behaviors associated with HIV transmission among transgender women. Participants who received any TLC component versus those who did not were compared using mixed-effects logistic regression with random intercepts across follow-up time points. Ninety-seven participants aged 18 to 59 (median age 24) enrolled; 76.3% were transgender women of color. There was a decrease in condomless sex without consistent PrEP use at 8 months, which was not significantly different between those who did and did not receive the TLC intervention, controlling for calendar time. Evidence does not indicate that the TLC reduces condomless sex without PrEP protection among urban transgender women. However, given the preponderance of evidence of the influence of structural barriers on condomless sex, future research should continue to test the efficacy of structural interventions.


Assuntos
Infecções por HIV , Pessoas Transgênero , Humanos , Feminino , Pessoas Transgênero/psicologia , Pessoas Transgênero/estatística & dados numéricos , Infecções por HIV/prevenção & controle , Chicago , Adulto , Masculino , Pessoa de Meia-Idade , Adolescente , Adulto Jovem , Profilaxia Pré-Exposição/métodos , Sexo sem Proteção/estatística & dados numéricos , Avaliação de Programas e Projetos de Saúde , Preservativos/estatística & dados numéricos , Comportamento Sexual , Conhecimentos, Atitudes e Prática em Saúde , Modelos Logísticos
3.
AIDS Educ Prev ; 33(4): 345-360, 2021 08.
Artigo em Inglês | MEDLINE | ID: mdl-34370565

RESUMO

In the United States, transgender women are disproportionately affected by HIV. However, few evidence-based prevention interventions exist for this key population. We describe two promising, locally developed interventions that are currently being implemented and evaluated through the Centers for Disease Control and Prevention Combination HIV Prevention for Transgender Women Project: (a) ChiCAS, designed to promote the uptake of pre-exposure prophylaxis (PrEP), condom use, and medically supervised hormone therapy among Spanish-speaking transgender Latinas, and (b) TransLife Care, designed to address the structural drivers of HIV risk through access to housing, employment, legal services, and medical services, including HIV preventive care (e.g., PrEP use) among racially/ethnically diverse urban transgender women. If the evaluation trials determine that these interventions are effective, they will be among the first such interventions for use with transgender women incorporating PrEP, thereby contributing to the evidence-based resources that may be used to reduce HIV risk among this population.


Assuntos
Fármacos Anti-HIV , Infecções por HIV , Profilaxia Pré-Exposição , Pessoas Transgênero , Fármacos Anti-HIV/uso terapêutico , Centers for Disease Control and Prevention, U.S. , Feminino , Infecções por HIV/prevenção & controle , Humanos , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa